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INTRODUCTION
The average 12-month prevalence of 
anxiety disorders is 6.7% in the general 
population,1 reaching 18.5% in patients in 
primary care.2 Between 2007 and 2017, 
the burden of disease in terms of years 
lived with disability attributable to anxiety 
disorders increased by 12.4% and 13.6% 
for females and males, ranking eighth and 
13th in the world, respectively.3 Although 
treatments for anxiety disorders are 
effective,4 not everyone with anxiety will 
receive appropriate treatment.5 Moreover, 
treatment alone is not sufficient to 
eliminate the disease burden imposed by 
anxiety disorders.6 It will be very difficult to 
decrease this burden unless the incidence 
of new cases is reduced, and this is only 
possible through primary prevention.
Psychological and/or educational 
interventions are effective at preventing 
anxiety disorders.7 Most preventive 
programmes delivering cognitive behaviour 
therapy have been carried out in an academic 
setting and administered by psychologists. 
Four trials on anxiety prevention have 
been conducted in primary care, and only 
two implemented by GPs.7 The primary 
healthcare setting is ideal for preventing 
the onset of illnesses, such as anxiety 
disorders, because it is easily accessible, 
provides continuity of care, and is used 
by a large proportion of the population.8,9 
To the authors’ knowledge, there are no 
interventions administered by GPs to prevent 
the onset of anxiety disorders in the adult 
population irrespective of people’s individual 
risk levels (universal prevention).7,10
Anxiety and depression frequently occur 
together,11 share most of the same risk 
factors,12–14 and respond to the same 
treatments15 and preventive interventions.16,17 
The authors’ research group (the predictD 
group) developed a personalised novel 
biopsychosocial intervention, the predictD-
intervention, based on the patient’s individual 
level of risk and risk profile of depression, 
which can be implemented by GPs to 
Abstract
Background
In the predictD-intervention, GPs used a 
personalised biopsychosocial programme to 
prevent depression. This reduced the incidence of 
major depression by 21.0%, although the results 
were not statistically significant.
Aim
To determine whether the predictD-intervention 
is effective at preventing anxiety in primary care 
patients without depression or anxiety.
Design and setting
Secondary study of a cluster randomised trial 
with practices randomly assigned to either the 
predictD-intervention or usual care. This study 
was conducted in seven Spanish cities from 
October 2010 to July 2012. 
Method
In each city, 10 practices and two GPs per 
practice, as well as four to six patients every 
recruiting day, were randomly selected until there 
were 26–27 eligible patients for each GP. The 
endpoint was cumulative incidence of anxiety as 
measured by the PRIME-MD screening tool over 
18 months.
Results
A total of 3326 patients without depression and 
140 GPs from 70 practices consented and were 
eligible to participate; 328 of these patients were 
removed because they had an anxiety syndrome 
at baseline. Of the 2998 valid patients, 2597 
(86.6%) were evaluated at the end of the study. 
At 18 months, 10.4% (95% CI = 8.7% to 12.1%) of 
the patients in the predictD-intervention group 
developed anxiety compared with 13.1% (95% 
CI = 11.4% to 14.8%) in the usual-care group 
(absolute difference = –2.7% [95% CI = –5.1% to 
–0.3%]; P = 0.029).
Conclusion
A personalised intervention delivered by GPs for 
the prevention of depression provided a modest 
but statistically significant reduction in the 
incidence of anxiety.
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prevent the onset of major depression.18 This 
intervention provided a modest reduction in 
the incidence of major depression compared 
with usual care.19 It was not statistically 
significant, but it had a relevant cost utility.20 
The aim of this secondary study was to 
assess whether the predictD-intervention for 
the prevention of depression was effective at 
preventing anxiety in patients in primary care 
who did not have depression or anxiety.
METHOD
Design and setting
The predictD-Cluster, Controlled, 
Randomised Trial (predictD-CCRT)18 had two 
parallel groups (the predictD-intervention 
and usual care), with cluster assignment 
by practice, and 18-month follow-up. It was 
conducted in seven Spanish cities (Malaga, 
Granada, Jaen, Saragossa, Salamanca, 
Bilbao, and Barcelona) between October 
2010 and July 2012.
The Spanish National Health Service 
provides universal health coverage for 
citizens through a public system financed 
by taxes and is free at the point of use. 
Each patient is assigned to only one GP, 
who functions as a gatekeeper to the wider 
system. Patients can visit their GP as often 
as they want without having to pay for 
consultations, even when they do so for 
preventive reasons. Details of the trial 
design are provided elsewhere.18–20
Participants
Ten practices in each city and two GPs in 
each practice were randomly selected using 
closed opaque envelopes by an independent 
investigator who was centrally located but 
not part of the research team.
Four to six patients per day were 
randomly selected from among the patients 
who had recently been seen at the practices 
by independent research assistants using 
random numbers. GPs reviewed the lists 
of patients to identify those who met the 
exclusion criteria. This process continued 
until there were 26 to 27 eligible patients for 
each GP. The recruitment was performed 
from October 2010 to February 2011. All 
eligible patients were invited to participate, 
and those who agreed to do so were 
informed about the study by research 
assistants. Exclusion criteria for patients 
were age <18 or >75 years; inability to 
understand or speak Spanish; documented 
severe mental disorder (such as psychosis, 
bipolar disorder, or personality disorder), 
cognitive impairment, or terminal illness; 
being scheduled to be out of the city more 
than 4 months during the 18 months of 
follow-up; and representatives attending 
the surgery on behalf of the patient. Trained 
and independent interviewers administered 
the Composite International Diagnostic 
Interview (Depression section)21,22 at 
baseline, and patients with a diagnosis 
of major depression during the previous 
6 months were also excluded from the trial. 
For this secondary study, patients were 
removed if they had an anxiety syndrome 
in the previous 6 months, according to the 
Primary Care Evaluation of Mental Disorders 
(PRIME-MD-anxiety) questionnaire.23,24 
Randomisation and blinding
In each city, five practices were assigned to 
the control group and five to the intervention 
group. This random allocation was achieved 
using closed opaque envelopes by an 
independent investigator who was centrally 
located but not part of the research team. 
GPs and patients were not blind to group 
allocations. The interviewers who assessed 
outcomes and investigators who did the 
statistical analyses were blinded to group 
allocations.
Intervention
The predictD-intervention has been 
described in detail elsewhere.18,19 Before 
delivering the intervention, GPs attended 
a 10- to 15-hour training workshop (see 
Supplementary Annex S1 for details). GPs 
communicated to each patient their risk 
factors for depression and overall probability 
of developing depression using the Spanish 
version of the predictD algorithm12,25 (http://
www.predictplusprevent.com/Calculadora.
How this fits in 
To date, very few studies on the prevention 
of anxiety have been conducted in primary 
care and only two of these interventions 
were performed by GPs. In the predictD-
intervention, the GP informed each patient 
about their level of risk (probability) and 
specific risk factors for depression, and they 
agreed on a personalised biopsychosocial 
intervention to prevent depression 
(constituting different strategies for dealing 
with the risk factors of each patient 
and encouraging them to have healthy 
lifestyle habits and promote their personal 
resources). The predictD-intervention 
reduced the occurrence of new cases of 
major depression compared with usual GP 
care, although this reduction was modest. 
This secondary study showed that the 
predictD-intervention also had a modest 
effect in preventing anxiety at 18 months. 
The predictD-intervention seems promising, 
although further studies are needed to 
confirm and even improve these results.
British Journal of General Practice, February 2021  e96
php?idioma=en). They then gave patients 
a patient-oriented booklet about 
preventing depression; enabling patients 
to actively deal with their risk factors, 
and feel empowered; and constructed a 
tailored biopsychosocial intervention for 
each patient to prevent depression (see 
Supplementary Annex S2 for details about 
the different components of the predictD 
intervention, and Supplementary Figure S1 
for a theoretical model for the prevention 
of depression in primary care). GPs were 
given recommendations for conducting a 
GP–patient interview to prevent depression 
(see Supplementary Box S1 for details) 
and were directed to a 5-minute video 
showing a GP delivering an intervention 
online (see Supplementary Figure S2 for 
an example of the mechanisms provided 
by the GP to reduce the likelihood of 
becoming depressed after the intervention). 
GPs delivered interventions to patients at 
baseline and at 6- and 12-month follow-up 
visits, which each lasted 10–15 minutes. 
Patients in the predictD-intervention group 
also continued to receive usual care. 
GPs in the control group did not receive 
information about their patients’ profiles 
and levels of risk, nor did they attend the 
training workshop. Patients in the control 
group continued to receive usual care, and 
were assessed for depression, anxiety, and 
other information at the same intervals as 
patients in the intervention group.
Outcomes
The endpoint of the predictD-CCRT 
study was cumulative incidence of major 
depression at 18 months. The endpoint for 
this secondary study was the cumulative 
incidence of anxiety syndromes at 
18 months measured at 6, 12, and 18 months 
using the PRIME-MD questionnaire.23 
The Spanish version of PRIME-MD can 
classify patients who test positive for panic 
attacks, generalised anxiety, and other 
anxiety syndromes.24 A dichotomous anxiety 
variable was used to indicate when any of 
the three anxiety syndromes are present in 
a given patient. The cumulative incidence 
of anxiety syndromes was also evaluated at 
6 and 12 months. It should be noted that the 
PRIME-MD instrument is not recorded on 
ClinicalTrials.gov as a secondary outcome; 
however, it can be found in the protocol 
publication of this study.18 Additional 
information collected from patients, 
GPs, and practices is described in detail 
elsewhere (see Supplementary Annex S3 
for a summary).18–20 All patient variables 
were assessed at baseline and at 6, 12, 
and 18 months in both study groups. GPs 
participating in the trial completed a self-
administered questionnaire at baseline.
Statistical analysis
All analyses were performed using Stata 
(version 13.1) and participants were 
analysed according to their randomised 
group. The cumulative incidence of 
anxiety at 18 months in each study 
group was compared using generalised 
estimating equations to account for the 
cluster randomised design, with multiple 
imputation to account for missing outcomes. 
Generalised estimating equations were 
fitted with a binomial-family, logit-link 
function; terms for intervention group and 
baseline probability of depression were 
included; and an exchangeable correlation 
structure and robust standard errors were 
included for clustering on practice, whose 
intraclass correlation coefficient was 0.029. 
The statistical power of the secondary study 
sample was calculated a posteriori, and was 
33.2% (rho = 0.029; alpha = 0.05; incidence 
difference = –0.0267, N1 = 1514, N2 = 1484, 
number of clusters K1 = 35 and K2 = 35, 
average number of patients per cluster 
M1 = 43.26 and M2 = 42.4). It was decided 
a priori to adjust for baseline probability 
of depression18 because it was considered 
strongly predictive of the outcome and 
thus clinically prognostic.26,27 Standardised 
probabilities of anxiety during the 18-month 
study were calculated using the margins in 
Stata. Missing outcomes were accounted 
for using multiple imputations with chained 
equations,28 under a missing-at-random 
framework. Fifty imputed samples were 
generated and estimates were combined 
using Rubin rules.29 
Sensitivity analysis included the 
unadjusted incidence of anxiety at 
18 months; and the incidence of anxiety 
at 18 months adjusted for all unbalanced 
variables. Supplementary analyses were 
also carried out to evaluate the cumulative 
incidence of anxiety at 6 and 12 months. 
All P-values were two-sided and 
considered significant at ≤0.05. All 
confidence intervals (CI) were reported at 
95%.
RESULTS
Eligible patients at each stage of the study 
up to 18 months are shown in Figure 1 
(see Supplementary Figure S3 for selection 
of primary care centres and GPs). A 
total of 68.7% (n = 1889) patients agreed 
to participate in the control group, and 
76.1% (n = 1894) agreed to participate in the 
intervention group. Of the 1453 patients who 
declined to participate, 72.1% (n = 1048), 
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35 Primary care centres, 70 primary care
physicians, and 1514 patients
Did not attend = 109
At baseline
35 Primary care centres, 70 primary care 
physicians, and 1356 patients
35 Primary care centres, 70 primary 
care physicians, and 1317 patients
Did not attend = 124
35 Primary care centres, 70 primary 
care physicians, and 1390 patientsAt 6 months
At 12 months
At 18 months 
70 Primary care centres
140 Primary care physicians
8292 patients randomly selecteda  
35 Primary care centres
70 Primary care physicians
2488 Patients asked to take part
35 Primary care centres 
70 Primary care physicians
2748 Patients asked to take part
Randomisation of
primary care centres
70 Primary care centres
140 Primary care physicians
5236 Patients
594 Patients did not consent 859 Patients did not consent
35 Primary care centres
70 Primary care physicians
1894 Patients consented to participate
35 Primary care centres
70 Primary care physicians
1889 Patients consented to participate
231 Patients had major depression (by CIDI)
179 Patients had anxiety (by PRIME) 226 Patients had major depression (by CIDI)
149 Patients had anxiety (by PRIME)
3056 (37%) patients excluded: 1479 <18 and >75 years; 1039 attended the 
surgery on behalf of the person who had the appointment; 153 will be away
(>4 months) during the follow-up; 122 severe mental disorders; 121 did not speak
or understand Spanish; 88 cognitive impairment and 54 terminal illnesses
35 Primary care centres, 70 primary care 
physicians, and 1484 patients
1344 Received the intervention, 93 did not 
receive the intervention, and 47 no information
35 Primary care centres, 70 primary care 
physicians, and 1375 patients
1195 Received the intervention, 116 did not 
receive the intervention, and 64 no information
35 Primary care centres, 70 primary care 
physicians, and 1311 patients
1237 received the intervention, 73 did not 
receive the intervention, and 1 no information
35 Primary care centres, 70 primary care 
physicians, and 1280 patients
1484 Included in analysisc 1514 Included in analysisc
Did not attend = 82 
Recovered = 48b
Did not attend = 83 
Recovered = 44b
Did not attend = 89 
Recovered = 25b 
Did not attend = 53
Recovered = 22b
Control groupIntervention group
Figure 1. Study design and operation.
aSystematic random sampling, from the primary care physicians’ appointment lists at random starting points for each day and without replacement. bPatients who attended 
the respective evaluation point, but did not attend any previous point. cAnalyses conducted using multiple imputation to account for missing outcomes (240 intervention and 250 
control patients had missing outcome at 18 months). CIDI = Composite International Diagnostic Interview.
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provided information about their age and 
sex. Compared with participants, these 
non-participants were slightly more likely 
to be males (38.4% versus 36.5%) and were 
of similar age (50.5 versus 50.7 years). A 
total of 70 practices, 140 GPs, and 3326 
non-depressive primary care attendees 
were recruited at baseline. Of these, 328 
patients were removed because in the 
previous 6 months they had an anxiety 
syndrome. Therefore, this sub-sample 
was composed of 2998 primary care 
patients without depression or anxiety. 
Baseline characteristics of the participating 
practices are given in Table 1, and baseline 
characteristics of the GPs are given in 
Table 2 (see Supplementary Table S1 for 
details of baseline characteristics of the 
patients). 
Figure 1 describes the study design and 
operation. No centre was lost to follow-
up. Three GPs in the intervention group 
could not complete the trial (two because 
of illness and one because they moved to 
another practice). Other GPs who were 
trained in providing the intervention replaced 
them, with the approval of the steering 
committee, and provided interventions at 
6 and 12 months for the 65 patients who 
were affected. According to information 
provided by the GPs, 79.4% (n = 1178) of the 
patients participated in all three GP–patient 
interviews, 16.5% (n = 245) in two interviews, 
2.9% (n = 43) in one interview, and 1.2% 
(n = 18) in no interviews. Most interviews 
were carried out face to face, but some 
were done by telephone (1.3% at baseline 
[n = 19], 7.9% [n = 117] at 6 months, and 
8.6% [n = 128] at 12 months). 
At the end of the study (18 months), 1244 
(83.8%) patients in the intervention group 
and 1264 (83.5%) in the control group were 
evaluated for the cumulative incidence of 
anxiety. In the intervention group, 1244 
(83.8%) participants were evaluated for 
cumulative incidence of anxiety and 240 
(16.2%) participants had missing outcomes 
in the cumulative incidence of anxiety (and 
were imputed later). In the control group, 
1264 (83.5%) participants were evaluated 
for cumulative incidence of anxiety and 250 
(16.5%) participants had missing outcomes 
in the cumulative incidence of anxiety (and 
were also imputed later).
The predictD-intervention was effective at 
preventing anxiety at 18 months, because 
10.4% of patients in the intervention 
group (95% CI = 8.7% to 12.1%) developed 
anxiety compared with 13.1% in the control 
group (95% CI = 11.4% to 14.8%) (absolute 
difference = –2.67 percentage points; 95% 
CI = –5.05 to –0.28 percentage points; 
P = 0.029) (Table 3). The intervention was 
not statistically significant for prevention of 
anxiety at 6 months or 12 months, although 
the effectiveness seemed to increase over 
time (Table 3). The unadjusted analysis was 
not statistically significant, whereas the 
analysis adjusted for baseline depression 
plus additional covariates slightly increased 
the effectiveness and was statistically 
significant (absolute difference = –2.78 
percentage points; 95% CI = –4.95 to –0.62 
percentage points; P = 0.012, Table 3).
GPs reported no adverse effects 
associated with the intervention. Three 
patients in the intervention group contacted 
researchers with complaints about their 
GPs and to request a change of GP.
DISCUSSION
Summary
A personalised and novel intervention 
based on the level of risk and risk profile of 
depression involving adult patients at low, 
moderate, and high risk, and implemented 
by GPs, was effective in reducing the 
incidence of anxiety syndromes at 
18 months. The results of sensitivity 
analyses were consistent with a modest but 
robust effect. 
Strengths and limitations
This is the first randomised trial to evaluate 
the effectiveness of an intervention 
administered by GPs to prevent depression, 
which was effective in reducing the onset 
of anxiety disorders in the adult population. 
This novel intervention allows for both 
disorders to be addressed. A large sample of 
patients were recruited irrespective of their 
individual risk levels (universal prevention). 
Furthermore, the trial was delivered by GPs 
in their practices and was based on usual 
components of primary care; therefore, it 
Table 1. Baseline characteristics of the primary care centres 
included in the study
 Control group Intervention  
Variable (n = 35)a group (n = 35)a
Years in operation, mean (SD) 18.9 (9.90) 20.5 (7.29)
Enrolled population, mean (SD) 19 992 (6739) 20 331 (10 014)
Number of primary care physicians, mean (SD) 11.6 (3.94) 12.1 (5.83)
Number of primary care paediatricians, mean (SD) 2.5 (1.04) 2.6 (1.31)
Number of primary care nurses, mean (SD) 12.0 (4.08) 12.3 (5.33)
Primary care social workers, n (%)
Half-time or less 19 (54.3) 16 (45.7)
More than half-time 16 (45.7) 19 (54.3)
aThere were no missing values. SD = standard deviation.
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will require little adaptation. This study had 
several limitations that must be taken into 
account. The predictD-intervention was 
performed with the aim of preventing major 
depression; therefore, this study addresses 
a secondary objective. The questionnaire 
used to evaluate the outcome, PRIME-MD, 
has good reliability and validity indices,23-24 
but it is not possible to rule out classification 
bias. Moreover, only a syndromic approach 
was considered as defined by the PRIME-
MD (generalised anxiety, panic disorders, 
and non-specific anxiety). 
Although patients were randomly selected 
by independent research assistants, a 
potential self-selection bias by patients was 
possible because there were more refusals 
to participate in the control group than in 
Table 2. Baseline characteristics of the family physicians involved in the study 
 Control group (N = 70)  Intervention group (N = 70)  
Variable n (%) or mean (SD) n (%) or mean (SD)
Sex (male) 29 (41.4%)b 28 (41.2%)d
Age (years) 53.8 (5.97)d 52.1 (7.13)e
Size of town where practice located d d
2500–30 000 inhabitants 10 (14.7%) 13 (19.1%)
30 001–200 000 inhabitants 10 (14.7%) 11 (16.2%)
>200 000 inhabitants 48 (70.6%) 44 (64.7%)
Primary care physician list size 1581 (166.02)f 1538 (244.95)g
Year doctor qualified  1983 (5.84)b 1984 (7.07)e
Time working at the health centre (months) 87.1 (46.20)b 79.8 (45.3)d
Average time spent per patient <10 minutesa 39 (55.7%)b 41 (60.3%)d
Relationship with mental health team (good/very good) 48 (70.6%)d 36 (53.7%)e
Satisfaction with support from mental health team c d
Very dissatisfied/dissatisfied 15 (21.7%) 14 (20.6%)
Neither dissatisfied nor satisfied 19 (27.5%) 25 (36.8%)
Satisfied/very satisfied 35 (50.7%) 29 (42.6%)
Ease and familiarity with handling antidepressants b d
Very uncomfortable/uncomfortable/neither uncomfortable nor comfortable 10 (14.3%) 18 (26.5%)
Comfortable/very comfortable 60 (85.7%) 50 (73.5%)
Relationship with primary care nurses (good/very good) 62 (88.6%)b 59 (86.8%)d
Active role of primary care nurse with patients with mental health disorders b d
Strongly disagree/disagree 22 (31.4%) 30 (44.1%)
Neither disagree nor agree 23 (32.9%) 20 (29.4%)
Agree/strongly agree 25 (35.7%) 18 (26.5%)
Relationship with primary care social workers (good/very good) 49 (70%)b 45 (66.2%)d
Active role of primary care social worker with patients with mental health disorders b d
My team has no primary care social worker 6 (8.6%) 8 (11.4%) 
Strongly disagree/disagree 16 (22.9%) 14 (20.0%)
Neither disagree nor agree 23 (32.9%) 27 (38.6%)
Agree/strongly agree 24 (34.3%) 18 (25.7%)
Style of professional practice
Job satisfaction (range 4–20) 16.44 (2.32)b 16.09 (2.32)d 
Perception workload (range 4–20) 14.67 (2.74)e 14.26 (3.65)d 
Biomedical versus psychosocial orientation (range 4–20) 10.25 (2.96)d 10.38 (3.56)d 
Extraversion (EPQR-A) Low (0 to 4 score) 35 (51.5%)d 38 (57.6%)f 
Neuroticism (EPQR-A) Low (0 to 4 score) 67 (95.7%)b 64 (95.5%)e
Psychoticism (EPQR-A) Low (0 to 4 score) 68 (98.6%)c 63 (94.0%)e
Long-term contract (yes) 65 (92.9%)b 63 (92.6%)d
Accredited to train residents (yes) 37 (52.9%)b 37 (54.4%)d
Training fourth-year resident (yes) 25 (35.7%)b 24 (35.3%)d
Training first-year resident (yes) 17 (24.6%)c 16 (22.9%)e
Three-to-four year postgraduate training (yes) 41 (58.6%)b 42 (61.8%)d
Member of the Communication & Health group (yes) 6 (8.6%)b 5 (7.4%)d
aRegardless of time per patient assigned on the agenda, what is your average time spent per patient (<10 minutes or ≥10 minutes)? Missing values, number (%): b0 (0%); c1 (1.4%); 
d2 (2.8%); e4 (4.3%); f4 (5.7%); g5 (7.1%). SD = standard deviation.
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the intervention group. This, along with the 
cluster randomisation, could explain the 
relative imbalance at the patient level.30,31 
Patients in the control group were more 
satisfied with home life and felt safer than 
patients in the intervention group, which 
might have made them generally less likely 
to develop an anxiety disorder. Similarly, 
control GPs were more comfortable in 
their relationships with mental health 
teams, social workers, nurses, and use of 
antidepressants than were intervention GPs. 
When all these variables were adjusted for 
in the sensitivity analysis, the effectiveness 
in preventing anxiety was slightly increased 
(Table 3). Finally, the sample possibly 
underrepresented patients who are treated 
infrequently;32 however, those who are seen 
frequently are more likely to develop anxiety 
disorders,33 and therefore have the most 
need for preventive strategies.
Comparison with existing literature
An intervention to prevent major depression 
that also reduces the incidence of anxiety 
syndromes could be explained by the fact 
that depression and anxiety share most 
of the same risk factors,12,13 and it is also 
possible that both are expressions of a latent 
pathological process.34 Many interventions 
have been developed for the prevention 
of both anxiety and depression disorders, 
showing successful results in both cases.15,16 
Transdiagnostic interventions seem to be a 
promising approach, and those aimed at 
preventing both depression and anxiety are 
increasing.35,36 The clinical practice guides 
consider the use of antidepressants as one 
of the treatments of choice for generalised 
anxiety disorders and panic disorder.37,38
It is possible that the preventive effect 
on depression of the predictD-intervention 
generated the reduction in anxiety through 
the modification of a set of shared risk 
between anxiety and depression.39 
Moreover, the mediators of psychological 
and psychoeducational interventions for the 
prevention of depression and anxiety are 
quite similar, being the change in cognitions 
as the main mediator of both conditions.40 
Another non-exclusive hypothesis might 
be that the predictD-intervention first 
reduced the incidence of anxiety and then 
the incidence of depression or vice versa. 
Evidence indicates that anxiety disorders 
temporally precede depression in most 
comorbid cases41 and that treatment for 
an anxiety disorder also produces declines 
in mood disorders.42 On the other hand, 
it might be that the predictD-intervention 
improves people’s mental health in 
general, leading to prevention of anxiety 
and depression at once.
The reduction in anxiety syndromes was 
about the same size as reductions reported 
in other studies that have evaluated 
psychological interventions to reduce 
separately the incidence of anxiety and 
depression.7,43,44 However, several studies 
found greater reductions in the incidence of 
panic disorder.45,46
The reduction of the incidence of anxiety 
in the current study seemed to increase 
over time, which might be due to a dose–
response effect of the intervention or simply 
a need for time and the accumulation of 
intervention visits to create the changes 
needed to prevent anxiety. A similar 
finding was observed for the reduction of 
the incidence of depression through the 
predictD-intervention,19 but this was not 
so in other interventions for the primary 
prevention of anxiety.7,47,48 
Most studies into the prevention of anxiety 
and depression examined interventions with 
a cognitive behaviour orientation, which have 
been administered by psychologists.7,43,44 In 
the current study, the predictD-intervention 
is based on each patient’s individual risk 
for major depression, identifies specific 
risk factors for depression in each 
patient that are amenable to change, and 
helps the patient use this information to 
improve knowledge and alter behaviour. 
Furthermore, it is delivered by GPs in their 
practices. 
Table 3. Effectiveness of the study intervention: proportion of 
patients with anxiety during the studya
 Intervention group Control group   
 (n = 1484, %) (n = 1514, %)  Absolute difference 
Variable (95% CI) (95% CI) % points (95% CI) P-value
Primary analysis
Anxiety at 18 months 10.43 (8.73 to 12.13) 13.10 (11.4 to 14.79) –2.67 (–5.05 to –0.28) 0.029
Secondary analysis
Anxiety at 6 months  4.55 (3.16 to 5.95) 5.18 (4.04 to 6.32) –0.63 (–2.43 to 1.17) 0.492
Anxiety at 12 months 7.99 (6.43 to 9.55) 9.56 (8.14 to 10.98) –1.57 (–3.67 to 0.54) 0.145
Sensitivity analysis
Anxiety at 18 months,  10.69 (8.91 to 12.46) 12.83 (10.88 to 14.79) –2.14 (–4.78 to 0.50) 0.112 
unadjusted
Anxiety at 18 months, 10.36 (8.81 to 11.91) 13.14 (11.62 to 14.67) –2.78 (–4.95 to –0.62) 0.012 
adjusted for all  
unbalanced variablesb
aDisplays standardised probabilities or predicted margins estimated using generalised estimating equations 
including an exchangeable correlation structure and robust standard errors for clustering on centre and adjusted 
for baseline probability of depression. bAdjusted for baseline probability of depression, the other unbalanced 
baseline variables not included in the predictD-Spain risk algorithm (employment status, owner/occupier of an 
accommodation, perception of safety inside/outside the home, and experiences of discrimination), GPs’ familiarity 
and ease in their relationships with mental health teams, social workers, nurses, and use of antidepressants, and 
city. CI = confidence interval.
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Implications for research and practice
A personalised intervention based on 
the level and risk profile of depression 
implemented by GPs provided a modest 
but statistically significant reduction in the 
incidence of anxiety. Although the effect 
size was a small decrease in anxiety 
incidence in the predictD-intervention 
group in comparison with the usual-care 
group), these relative numbers could be 
clinically relevant in absolute terms. From 
the perspective of public health, small 
effects on prevention could have a high 
impact, avoiding anxiety and depression, 
improving quality of life, and reducing costs, 
if the interventions are cost-effective and 
scalable to a large number of people, which 
is possible in a primary care setting. From 
this perspective, and bearing in mind the 
findings, healthcare systems could be 
encouraged to implement and disseminate 
prevention programmes for both anxiety 
and depression disorders rather than for 
each disorder alone.49 The fact that the 
predictD-intervention was cost-effective for 
the prevention of depression when delivered 
by GPs in their practices20 would facilitate 
its implementation. However, it remains to 
be clarified whether universal prevention 
of anxiety and depression in primary care is 
more cost-effective and acceptable for GPs 
and patients than selective prevention in 
patients who are high-risk.
In general, patients were pleased to be 
informed about their risk for depression,50 
and the GPs had a positive experience 
with the predictD-intervention, as it was 
easily embedded into their practice.51 They 
perceived it useful as a biopsychosocial 
approach for improving the emotional health 
of patients and their relationship with them, 
as well as their own satisfaction as a GP. 
However, they also detected some barriers 
such as lack of time, and the need for 
specific training to effectively communicate 
the risk of developing depression.51 For the 
future implementation of the predictD-
intervention, GPs suggested intervention 
based on level of risk. From their point of 
view, having to carry out an intervention 
in all patients regardless of their level of 
risk (universal prevention) is an unrealistic 
workload.51
It is not known how important patient 
initiative (dealing with their risk factors, 
overcoming difficulties, as well as starting 
healthy behaviours) and empowerment 
were in the predictD-intervention, nor which 
or how many of the components of the 
intervention were involved in each case. 
Studies to define the active ingredients of the 
intervention are therefore also necessary. 
The predictD-intervention seems promising, 
but further studies to confirm and even 
improve these results are needed.
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